IRCT2016101030255N1
Completed
Early Phase 1
The Effectiveness of the adjuvant treatment with a compound of sedge plant, saffron and honey to conventional treatment for improvement of cognitive performance of patients with dementia
Vice Chancellor for research of Isfahan University of Medical Sciences0 sites60 target enrollmentTBD
Overview
- Phase
- Early Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Vice Chancellor for research of Isfahan University of Medical Sciences
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\-Upper 50 years old; 2\-slight to moderate dementia according DSM\-IV criteria; 3\-acceptance to enter this project; 4\-under drug therapy.
- •Exclusion criteria: 1\-Mental retardation according DSM\-IV criteria; 2\-Side effect that patients couldn’t continue these herbal drugs such as gastrointestinal side effect; 3\-other psychiatrist disorder; 4\-using other herbal medicine, or using other traditional treatment such as homeopathy.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Evaluation of the benefit of using hydroxychloroquine for uncomplicated term pregnancy in patients with primary obstetric antiphospholipid syndromePrimary obstetrical antiphospholipid syndromeMedDRA version: 20.0Level: PTClassification code 10002817Term: Antiphospholipid syndromeSystem Organ Class: 10005329 - Blood and lymphatic system disordersTherapeutic area: Diseases [C] - Immune System Diseases [C20]EUCTR2017-004866-86-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)110
Completed
Phase 2
Efficacy and Safety study of adjuvant therapy with capecitabine plus oxaliplatin (XELOX) for the Japanese patient with Stage III curative resection Colon cancer -Phase II studyColon cancerJPRN-UMIN000006742Multicenter Study Group of Osaka (MCSGO), Colorectal Cancer Treatment Group195
Completed
Not Applicable
The phase I/II study of the adjuvant therapy using alpha-galactosylceramide pulsed dendritic cells for patients with advanced high-grade salivary gland tumor followed by standard therpies.Salivary gland tumorJPRN-UMIN000024669Chiba University Hospital6
Completed
Phase 1
The phase I/II study of the adjuvant therapy using alpha-galactosylceramide pulsed antigen presenting cells for patients with high-grade salivary grand tumor followed by standard therpies.High-grade salivary grand tumorJPRN-UMIN000011509Department of Otorynolaryngology, Head and Neck Surgery, Graduate School of Medicine, Chiba University9
Recruiting
Not Applicable
Clinical efficacy study of neoadjuvant therapy with intensity-modulated radiotherapy combined with S-1 for resectable pancreatic cancerpancreatic cancerJPRN-UMIN000046456Kyoto Katsura Hospital40